XUR-25912-78926 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-24
Registered in v-safe
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Survey response — days 1–6 daily, dose 1
MedDRA: Pain, Pain in extremity — Feeling: Good

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Diarrhea, Abdominal pain · Be unable to work

Adult check-in
2020-12-29
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-30
Health check-in — 7 day, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-01-06
Survey response — 14 day, dose 1
MedDRA: Chest discomfort, Chest pain, Chills, Fatigue — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-06
Report sent to call center — 14 day, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Survey response — 21 day, dose 1
MedDRA: Exposure to SARS-CoV-2 — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-13
Report sent to call center — 21 day, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Dose 2 — Pfizer-BioNTech
2021-01-22
Survey response — days 1–6 daily, dose 2
MedDRA: Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Fatigue or tiredness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — 7 day, dose 2
Feeling: Good · None

Adult check-in
2021-02-04
Health check-in — 14 day, dose 2
Feeling: Fair

Adult check-in
2021-02-11
Health check-in — 21 day, dose 2
Feeling: Fair

Adult check-in
2021-02-18
Health check-in — 28 day, dose 2
Feeling: Good

Adult check-in
2021-02-25
Health check-in — 35 day, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — 42 day, dose 2
Feeling: Good

Adult check-in
2021-04-22
Survey response — 3 month, dose 2
MedDRA: Fatigue — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-07-22
Health check-in — 6 month, dose 2
Feeling: Good

Adult check-in
2022-01-21
Survey response — 12 month, dose 2
MedDRA: Arthralgia, Breakthrough COVID-19, Dyspnoea, Fatigue, Headache — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

MedDRA releases: 2024-11 · check-in answers available
2022-01-21
Report sent to call center — 12 month, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-01-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-21	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-29	priority 2/3
2021-01-06	priority 2/3
2021-01-13	priority 2/3
2022-01-21	Unsuccessful

Free text

Release 1

Systemic reaction (other): Movement of arm hurts not the site

Symptoms: Heavy feeling in chest Chest painChills no tempFatigue

Symptoms: High risk exposure at work to covid positive co worker Have symptoms, on home iolation the 1/19 per MDH.Rescheduled second vacination to 1/21 after isolation per CDC recommendation

Release 2

Systemic reaction (other): Arm is very sore

Release 7

Symptoms: Fatigue everyday

Release 10

Symptoms: Break thru severe case of covid-19 11/2021. Received monoclonal antibodies Cardiac and air hunger/ sob since, headaches, joint pain and chronic fatigue

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	·	·	✓
SD	Breakthrough COVID-19	·	·	✓
SD	Chest discomfort	✓	✓	✓
SD	Chest pain	✓	✓	✓
SD	Chills	✓	✓	✓
SD	Dyspnoea	·	·	✓
SD	Exposure to SARS-CoV-2	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	·	·	✓
SRO	Pain	✓	✓	✓
SRO	Pain in extremity	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release